Analytical Data
-
Gene name
FAM110A
- Application
-
Alternative Names
FAM110A. C20orf55. F10
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9BQ89
-
Expression Region
1-295aa
-
AA Sequence
MPVHTLSPGAPSAPALPCRLRTRVPGYLLRGPADGGARKPSAVERLEADKAKYVKSLHVANTRQEPVQPLLSKQPLFSPETRRTVLTPSRRALPGPCRRPQLDLDILSSLIDLCDSPVSPAEASRTPGRAEGAGRPPPATPPRPPPSTSAVRRVDVRPLPASPARPCPSPGPAAASSPARPPGLQRSKSDLSERFSRAAADLERFFNFCGLDPEEARGLGVAHLARASSDIVSLAGPSAGPGSSEGGCSRRSSVTVEERARERVPYGVSVVERNARVIKWLYGLRQARESPAAEG
-
Molecular Weight
57.7 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
FAM110A, a member of the FAM110 family of proteins, has garnered significant interest in the field of molecular biology due to its potential roles in various cellular processes. Initially identified as a gene implicated in cell cycle regulation and development, FAM110A has been linked to crucial functions such as cell proliferation, differentiation, and apoptosis. Research suggests that FAM110A may have a role in maintaining genomic stability and responding to cellular stress, making it a candidate for exploration in cancer biology and other diseases characterized by dysregulated cell growth. Moreover, recent studies have indicated that FAM110A could participate in signaling pathways and cellular interactions, further underscoring its importance in physiological and pathological contexts. The recombinant expression of FAM110A is essential for elucidating its structure-function relationships and for understanding its mechanistic roles in cellular processes. By producing FAM110A in a recombinant form, researchers aim to investigate its interactions with other proteins, assess its activity in vitro, and explore its potential as a therapeutic target. This focus on FAM110A aligns with the broader trend of delving into the functional roles of lesser-known proteins in cancer research and regenerative medicine, offering prospects for novel therapeutic interventions and enhancing our understanding of cellular dynamics.
